Component
Human basal secretion of newly synthesized VLDL triglyceride
Species, exposure, manipulation and evidence limits are specified on each linked claim.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
Fructose did not increase basal secretion of newly synthesized VLDL triglyceride in that trial.
Experimental context and source evidence
- dose
- Fructose, sucrose or glucose 80 g/day versus sweetened-beverage abstinence
- duration
- 7 weeks
- evidence_access
- Primary abstract/metadata; unrecovered methods explicitly retained.
- evidence_scope
- literature_reviewed; source-specific curation
- experimental_model
- 94 healthy men completing randomized beverage intervention
- exposure_scope
- Component sugars and sucrose
- limitations
- Total reported energy intake was similar across groups; this was not a metabolic-ward clamp. Fractional fatty-acid synthesis is distinct from total liver fat and VLDL-TG output. No HFCS arm.
- nutrient_topic
- HFCS chapter: actual formulation studies, component biochemistry and interventions are explicitly distinguished. · High-Fructose Corn Syrup / HFCS
- organism
- 94 healthy men completing randomized beverage intervention
- plain_language
- Fructose did not increase basal secretion of newly synthesized VLDL triglyceride in that trial.
- primary_references
- Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: A randomized controlled trial. (2021). https://pubmed.ncbi.nlm.nih.gov/33684506/ DOI: 10.1016/j.jhep.2021.02.027
- route
- Oral beverages in addition to usual diet
- tissue
- Stable-isotope hepatic lipid synthesis
High-Fructose Corn Syrup: mechanism of action and metabolic impact (2026-09-20) · lines 413–423
Original AI-assisted curation of twenty primary studies and official FDA composition information, with one reused canonical glucose-transport claim. Study-specific citations, negative findings and limitations retained. Not publisher full text. · supports · 94 healthy men completing randomized beverage intervention · source_derived_draft · unverified_draft
## hfcs-vldl-null Fructose did not increase basal secretion of newly synthesized VLDL triglyceride in that trial. Model/species: 94 healthy men completing randomized beverage intervention Tissue: Stable-isotope hepatic lipid synthesis Exposure: Fructose, sucrose or glucose 80 g/day versus sweetened-beverage abstinence Route: Oral beverages in addition to usual diet Duration: 7 weeks Exposure scope: Component sugars and sucrose Limits: Total reported energy intake was similar across groups; this was not a metabolic-ward clamp. Fractional fatty-acid synthesis is distinct from total liver fat and VLDL-TG output. No HFCS arm. Reference: Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: A randomized controlled trial. (2021). https://pubmed.ncbi.nlm.nih.gov/33684506/ DOI: 10.1016/j.jhep.2021.02.027 Access: Primary abstract/metadata; unrecovered methods explicitly retained.
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.